0J8Z

Illumina Inc.

Stock London Stock Exchange – Stock Market Prices, News & Analysis

Illumina Inc. conçoit, développe et commercialise des systèmes de séquençage et des solutions de génomique pour la recherche et les applications cliniques.

£ 1.28
1.58 %

Illumina Inc.

£ 1.28
1.58 %
0J8Z

Illumina Inc. conçoit, développe et commercialise des systèmes de séquençage et des solutions de génomique pour la recherche et les applications cliniques.

Price history of Illumina Inc.
Price history of Illumina Inc.

Performance & Momentum

6 Months 31.66 %
1 Year 50.48 %
3 Years 39.70 %
5 Years 67.12 %

Strategic Analysis

Illumina Inc. • 2026

Illumina Inc. is a global leader in genomic sequencing , combining innovation and precision in its solutions for biomedical research and clinical applications. Its business model is based on strong technological differentiation in a rapidly expanding healthcare sector where genomics plays a key role in personalized medicine.

Strengths
  • Leading position in DNA sequencing recognized for their reliability and performance
  • Established presence in a growing market linked to diagnostics and precision medicine
  • Strong technological expertise that creates a high barrier to entry for competitors
Weaknesses
  • Significant volatility over several years, affecting long-term investor confidence
  • Dependence on continuous innovation in a highly competitive environment
Momentum

After a prolonged period of underperformance, Illumina has shown a significant rebound over recent months, reflecting renewed market interest in its growth prospects. This positive momentum suggests monitoring the company's innovation pipeline as well as its strategic repositioning in a dynamic sector.

Similar stocks to Illumina Inc.

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone